Table 1.

Demographics and characteristics of survey responders

Characteristic	Number (%)
Country of Practice
USA-based	79 (69 %)
Non USA-based	35 (31 %)
Gender
Male	82 (72 %)
Female	32 (28 %)
Age (median in years, ±standard deviation)	47 ± 10.3
Board-certification
Hematology	25 (22 %)
Medical oncology	13 (11 %)
Hematology/oncology	39 (34 %)
Pediatric hematology/oncology	27 (24 %)
Other	10 (9 %)
Job description
Clinical researcher	52 (46 %)
Clinician	47 (41 %)
Clinical educator	7 (6 %)
Basic science researcher	3 (3 %)
other	5 (4 %)
Number of years post-fellowship training
0–5 years	25 (22 %)
6–10 years	22 (19 %)
11–20 years	29 (25 %)
21 or more years	38 (33 %)
Type of institution of Practice
University affiliated/Public	91 (80 %)
Private	22 (19 %)
Military	1 (1 %)
Number of HSCT performed at the institution per year
100 or less	62 (54 %)
101–250	30 (26 %)
More than 250	22 (19 %)
Institution’s approach for documentation
Paper medical records only	7 (6 %)
Electronic medical records only	46 (40 %)
Mixture of electronic and paper medical records (or in transition)	61 (54 %)
Institution’s approach for provider order
Paper order entry only	25 (22 %)
Electronic order entry	45 (40 %)
Mixture of electronic and paper order entry (or in transition)	44 (39 %)
Is there a cancer-specific VTE prophylaxis order set at your institution?
Yes	37 (33 %)
No	65 (57 %)
Not sure	12 (11 %)
Is there a HSCT-specific VTE prophylaxis order set at your institution?
Yes	16 (14 %)
No	95 (83 %)
Not sure	3 (3 %)

VTE venous thromboembolism, HSCT hematopoietic stem cell transplantation